Selection of a novel drug-response predictor in esophageal cancer: a novel screening method using microarray and identification of IFITM1 as a potent marker gene of CDDP response.

MLA

Fumoto, Shoichi, et al. “Selection of a Novel Drug-Response Predictor in Esophageal Cancer: A Novel Screening Method Using Microarray and Identification of IFITM1 as a Potent Marker Gene of CDDP Response.” International Journal of Oncology, vol. 32, no. 2, Feb. 2008, pp. 413–23. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=18202764&authtype=sso&custid=ns315887.

APA

Fumoto, S., Shimokuni, T., Tanimoto, K., Hiyama, K., Otani, K., Ohtaki, M., Hihara, J., Yoshida, K., Hiyama, E., Noguchi, T., & Nishiyama, M. (2008). Selection of a novel drug-response predictor in esophageal cancer: a novel screening method using microarray and identification of IFITM1 as a potent marker gene of CDDP response. International Journal of Oncology, 32(2), 413–423.

Chicago

Fumoto, Shoichi, Tatsushi Shimokuni, Keiji Tanimoto, Keiko Hiyama, Keiko Otani, Megu Ohtaki, Jun Hihara, et al. 2008. “Selection of a Novel Drug-Response Predictor in Esophageal Cancer: A Novel Screening Method Using Microarray and Identification of IFITM1 as a Potent Marker Gene of CDDP Response.” International Journal of Oncology 32 (2): 413–23. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=18202764&authtype=sso&custid=ns315887.